ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,168 | -85.7% | 20,689 | -81.7% | 0.00% | – |
| Q2 2023 | $877,470 | -43.4% | 113,076 | -58.4% | 0.00% | – |
| Q1 2023 | $1,550,047 | +8.9% | 271,938 | +12.6% | 0.00% | – |
| Q4 2022 | $1,422,947 | +86.2% | 241,587 | +1.2% | 0.00% | – |
| Q3 2022 | $764,000 | -48.2% | 238,777 | -27.4% | 0.00% | – |
| Q2 2022 | $1,475,000 | +276.3% | 329,105 | +348.5% | 0.00% | – |
| Q1 2022 | $392,000 | -48.7% | 73,372 | +41.2% | 0.00% | – |
| Q4 2021 | $764,000 | +114.0% | 51,964 | +204.5% | 0.00% | – |
| Q3 2021 | $357,000 | -8.5% | 17,066 | -22.6% | 0.00% | – |
| Q2 2021 | $390,000 | -63.3% | 22,044 | -49.2% | 0.00% | – |
| Q1 2021 | $1,062,000 | – | 43,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |